Rinostat L 2.5mg/10mg Tablet
By Rinostat L
Rx
10 Tablet in a Strip

Composition
Levocetirizine(2.5mg) + Phenylephrine(10mg)

Manufacturer - RPG Life Sciences Ltd
463, 4 th Floor, RPG HOUSE, Dr. Annie Besant Road, Worli, Mumbai – 400 030. Maharashtra, INDIA

Expires on or after
September, 2025

liver
When using Rinostat L 2.5mg/10mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It is highly recommended to seek advice from your doctor before starting or adjusting the dosage of Rinostat L 2.5mg/10mg Tablet to ensure your safety and well-being.

kidney
Rinostat L 2.5mg/10mg Tablet needs caution in kidney disease. Consult your doctor for possible dosage adjustments. Avoid in severe kidney disease.

alcohol
Caution is advised when alcohol is consumed with Rinostat L 2.5mg/10mg Tablet. Consult your doctor for guidance.

driving
Rinostat L 2.5mg/10mg Tablet may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Rinostat L 2.5mg/10mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor to assess benefits and risks before using.

breastfeeding
Caution is advised when breastfeeding while using Rinostat L 2.5mg/10mg Tablet as it may be unsafe. Limited data suggests the drug can pass into breast milk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹75
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025